Related references
Note: Only part of the references are listed.Axonal transport and secretion of fibrillar forms of α-synuclein, Aβ42 peptide and HTTExon 1
Michel Brahic et al.
ACTA NEUROPATHOLOGICA (2016)
Cellular response of human neuroblastoma cells to α-synuclein fibrils, the main constituent of Lewy bodies
Laura Pieri et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
Interactions between misfolded protein oligomers and membranes: A central topic in neurodegenerative diseases?
Maria Andreasen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
α-synuclein assemblies sequester neuronal α3-Na+/K+-ATPase and impair Na+ gradient
Amulya Nidhi Shrivastava et al.
EMBO JOURNAL (2015)
Human Hsp70 Disaggregase Reverses Parkinson's-Linked α-Synuclein Amyloid Fibrils
Xuechao Gao et al.
MOLECULAR CELL (2015)
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
W. Peelaerts et al.
NATURE (2015)
Spreading of pathology in neurodegenerative diseases: a focus on human studies
Johannes Brettschneider et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Progressive Aggregation of Alpha-Synuclein and Selective Degeneration of Lewy Inclusion-Bearing Neurons in a Mouse Model of Parkinsonism
Valerie R. Osterberg et al.
CELL REPORTS (2015)
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
Staffan Holmqvist et al.
ACTA NEUROPATHOLOGICA (2014)
Co-existence of Two Different α-Synuclein Oligomers with Different Core Structures Determined by Hydrogen/Deuterium Exchange Mass Spectrometry
Wojciech Paslawski et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
The Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid Formation
Nikolai Lorenzen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Extracellular α-synuclein-a novel and crucial factor in Lewy body diseases
He-Jin Lee et al.
NATURE REVIEWS NEUROLOGY (2014)
Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice
Amanda N. Sacino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Dopamine-induced α-synuclein oligomers show self- and cross-propagation properties
Matthew S. Planchard et al.
PROTEIN SCIENCE (2014)
Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice
Nolwen L. Rey et al.
ACTA NEUROPATHOLOGICA (2013)
α-Synuclein oligomers and clinical implications for Parkinson disease
Lorraine V. Kalia et al.
ANNALS OF NEUROLOGY (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
α-Synucleinopathy phenotypes
Heather McCann et al.
PARKINSONISM & RELATED DISORDERS (2013)
Structural and functional characterization of two alpha-synuclein strains
Luc Bousset et al.
NATURE COMMUNICATIONS (2013)
Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons
Grit Taschenberger et al.
ACTA NEUROPATHOLOGICA (2012)
Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport
Eric C. Freundt et al.
ANNALS OF NEUROLOGY (2012)
Fibrillar α-Synuclein and Huntingtin Exon 1 Assemblies Are Toxic to the Cells
Laura Pieri et al.
BIOPHYSICAL JOURNAL (2012)
Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
Nunilo Cremades et al.
CELL (2012)
Prion-like acceleration of a synucleinopathy in a transgenic mouse model
Anne-Laure Mougenot et al.
NEUROBIOLOGY OF AGING (2012)
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Kelvin C. Luk et al.
SCIENCE (2012)
Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers
He-Jin Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2011)
Hsc70 Protein Interaction with Soluble and Fibrillar α-Synuclein
Samantha Pemberton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
Christian Hansen et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells
Kentaro Yamakawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Methionine oxidation stabilizes non-toxic oligomers of α-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions
Wenbo Zhou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Stable α-Synuclein Oligomers Strongly Inhibit Chaperone Activity of the Hsp70 System by Weak Interactions with J-domain Co-chaperones
Marie-Pierre Hinault et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease
T. Tokuda et al.
NEUROLOGY (2010)
Endogenous catecholamine enhances the dysfunction of unfolded protein response and alpha-synuclein oligomerization in PC12 cells overexpressing human alpha-synuclein
Satoru Ito et al.
NEUROSCIENCE RESEARCH (2010)
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Jan Bieschke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models
Damla Pinar Karpinar et al.
EMBO JOURNAL (2009)
Seeding induced by α-synuclein oligomers provides evidence for spreading of α-synuclein pathology
Karin M. Danzer et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Modulation of α-Synuclein Aggregation by Dopamine: A Review
Su Ling Leong et al.
NEUROCHEMICAL RESEARCH (2009)
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Paula Desplats et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
α-synuclein protofibrils inhibit 26 S proteasome-mediated protein degradation -: Understanding the cytotoxicity of protein protofibrils in neurodegenerative disease pathogenesis
Nan-Yan Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E. Ehrnhoefer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Different species of α-synuclein oligomers induce calcium influx and seeding
Karin M. Danzer et al.
JOURNAL OF NEUROSCIENCE (2007)
Effect of 4-hydroxy-2-nonenal modification α-synuclein aggregation
Zhijie Qin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Cytosolic catechols inhibit α-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates
Joseph R. Mazzulli et al.
JOURNAL OF NEUROSCIENCE (2006)
Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra
James E. Galvin
ACTA NEUROPATHOLOGICA (2006)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
PA700, the regulatory complex of the 26S proteasome, interferes with α-synuclein assembly
M Ghee et al.
FEBS JOURNAL (2005)
A protein-chameleon:: Conformational plasticity of α-synuclein, a disordered protein involved in neurodegenerative disorders
VN Uversky
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
α-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils
HA Lashuel et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Dopamine-dependent neurotoxicity of α-synuclein:: A mechanism for selective neurodegeneration in Parkinson disease
J Xu et al.
NATURE MEDICINE (2002)
Size-distribution analysis of proteins by analytical ultracentrifugation: Strategies and application to model systems
P Schuck et al.
BIOPHYSICAL JOURNAL (2002)
Vesicle permeabilization by protofibrillar α-synuclein:: Implications for the pathogenesis and treatment of Parkinson's disease
MJ Volles et al.
BIOCHEMISTRY (2001)
PAN, the proteasome-activating nucleotidase from archaebacteria, is a protein-unfolding molecular chaperone
N Benaroudj et al.
NATURE CELL BIOLOGY (2000)
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
KA Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling
P Schuck
BIOPHYSICAL JOURNAL (2000)
Share Paper
